InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
60%
T+90 mean return
+1.8%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Burt Carol, Director. Director active across 2 companies, notably RESMED INC. Aggregated, 19 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €1.3m. History available since 30 August 2021. The latest transaction was disclosed on 23 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
1,571 shares0Common StockSEC:0001628280-26-027596:0
1,083 shares0ResMed Common StockSEC:0001127602-24-027898:0
47 shares0ResMed Common StockSEC:0001127602-24-016513:0
234 shares0ResMed Common StockSEC:0001127602-24-013675:0
1,768 shares0ResMed Common StockSEC:0001127602-23-028141:0
1,768 shares0ResMed Common StockSEC:0001127602-23-028057:0
1,063 shares0Common StockSEC:0001478242-23-000070:0
1,122 shares0ResMed Common StockSEC:0001127602-22-026043:0
995 shares0Common StockSEC:0001478242-22-000073:0
1,500 shares@ US$260.000.0009% mcap27.6% of flowResMed Common StockSEC:0000943819-21-000043:0
1,500 shares@ US$260.0027.6% of flowResMed Common StockSEC:0000943819-21-000043
956 shares0ResMed Common StockSEC:0000943819-21-000041
956 shares0ResMed Common StockSEC:0000943819-21-000032
956 shares0ResMed Common StockSEC:0000943819-21-000032:0
956 shares0ResMed Common StockSEC:0000943819-21-000041:0
1,187 shares@ US$270.800.0007% mcap22.4% of flowResMed Common StockSEC:0001127602-21-029398:0
1,187 shares@ US$270.8022.4% of flowResMed Common StockSEC:0001127602-21-029398
347 shares0ResMed Common StockSEC:0001127602-21-024566:0
347 shares0ResMed Common StockSEC:0001127602-21-024566
19 of 19 declarations
About Burt Carol
Carol Burt is a Director at RESMED INC and IQVIA HOLDINGS INC. As a board member, she participates in the governance of the companies and in strategic decision-making. Her experience and leadership skills are valuable in guiding ResMed and IQVIA in their growth and innovation initiatives. She also contributes to ensuring compliance and accountability within the organizations.
